A Study to Compare the Efficacy and Safety of Ifosfamide and Etoposide With or Without Lenvatinib in Children, Adolescents and Young Adults With Relapsed and Refractory Osteosarcoma
Clinical trial NCT04154189 · COMPLETED
Trial details
- NCT number
- NCT04154189
- Sponsor
- Eisai Inc.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-03-23
- Primary completion
- 2022-06-22
- Enrollment
- 81
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.